Stock Market

Home > Markets-Economic Times > Biocon’s $1-billion biologics sales target ‘looks lofty’

Biocon’s $1-billion biologics sales target ‘looks lofty’

October 29, 2019
Access in healthcare medication is a big concern globally and insulin prices have been soaring in recent years.

from Markets-Economic Times https://ift.tt/32Y3pVx

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.